Stocks · News reference
Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Fortive Corporation announced its third-quarter 2026 financial results, reporting revenue of $1.108 billion and adjusted earnings per share of $0.77, while raising its full-year 2026 adjusted earnings outlook.
Fluke Corporation, a subsidiary of Fortive, has introduced the 7508, 7511, and 7512 refrigerated temperature calibration baths designed for high-accuracy sensor testing.
Filed: 2026-10-28 AccNo: 0001659166-26-000039 Size: 656 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Fluke Networks, a Fortive subsidiary, introduced new inspection tips for its FI-3000 FiberInspector™ Pro to improve fiber connection inspection in high-density data centers.
IonQ has received $7.5 million in additional funding from the U.S. Air Force Research Laboratory (AFRL) to further the development of its full-stack quantum networking technology.
IBM's core business remains stable with Q3 revenue up 5% to $17.1B and software revenue climbing 8%, but the company's quantum computing ambitions are viewed as the primary growth catalyst. IBM is developing fault-tolerant quantum computers using qLDPC error-correcting codes and has signed 16 enterprise quantum agreements this year. With a forward P/E of 19, the stock is valued at market multiples, and analysts view it as a good addition to a broader quantum computing portfolio.